• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Supporting Medical Labs During Tough Economic Times

Supporting Medical Labs During Tough Economic Times

by Rachel Muenz | Jun 6, 2023 | News, Open Content

G2 Intelligence’s June 13-14 virtual event offers expert advice to help labs navigate today’s economic challenges.

Sales and Marketing—Beyond COVID

Sales and Marketing—Beyond COVID

by G2 Intelligence Staff | May 8, 2023 | OLP, Webinars, webinars free

Learn numerous proven field strategies and tactics to help laboratory sales reps achieve success in today’s challenging environment.

Illegal Marketing Commissions Arrangements Cost Toxicology Lab $5.9 Million

Illegal Marketing Commissions Arrangements Cost Toxicology Lab $5.9 Million

by Glenn S. Demby | Apr 18, 2023 | News, Open Content

Recent case shows that toxicology labs and drug testing remain a primary target for federal enforcement agencies.

How to Reduce Liability Risk for Lab Sales and Marketing

How to Reduce Liability Risk for Lab Sales and Marketing

by Glenn S. Demby | Feb 24, 2023 | Compliance Perspectives-lca, Essential, Lab Compliance Advisor

A code of conduct for sales and marketing staff is essential to allow staff to do their jobs while avoiding liability risk.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
How to Explain the Current State of EKRA to Your Lab Executives

How to Explain the Current State of EKRA to Your Lab Executives

by Glenn S. Demby | Feb 24, 2023 | Brief Your CEO-lca, Essential, Lab Compliance Advisor, Reimbursement-lca

How to explain the current state of EKRA to your lab executives.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com